Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Rising High: Tilray reports Q4 earnings as GrowGeneration to acquire HGS Hydro » 11:44
07/29/21
07/29
11:44
07/29/21
11:44
ZYNE

Zynerba

$4.62 /

-0.06 (-1.28%)

, IGC

India Globalization Capital

$1.87 /

-0.01 (-0.53%)

, GTBIF

Green Thumb Industries

$29.60 /

+0.36 (+1.23%)

, GDNSF

Goodness Growth

$1.59 /

-0.005 (-0.31%)

, CANN

General Cannabis

/

+

, CVSI

CV Sciences

/

+

, CRON

Cronos Group

$7.65 /

+ (+0.00%)

, CGC

Canopy Growth

$20.04 /

+0.45 (+2.30%)

, CTST

CannTrust

/

+

, ACB

Aurora Cannabis

$7.31 /

+0.025 (+0.34%)

, TCNNF

Trulieve Cannabis

$32.36 /

+0.94 (+2.99%)

, CLVR

Clever Leaves

$9.94 /

-0.05 (-0.50%)

, IMCC

IM Cannabis

$5.13 /

+0.06 (+1.18%)

, GRWG

GrowGeneration

$41.78 /

-0.17 (-0.41%)

, TLRY

Tilray

$16.14 /

+0.14 (+0.88%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
$4.62 /

-0.06 (-1.28%)

TLRY Tilray
$16.14 /

+0.14 (+0.88%)

TCNNF Trulieve Cannabis
$32.36 /

+0.94 (+2.99%)

IMCC IM Cannabis
$5.13 /

+0.06 (+1.18%)

IGC India Globalization Capital
$1.87 /

-0.01 (-0.53%)

GTBIF Green Thumb Industries
$29.60 /

+0.36 (+1.23%)

GRWG GrowGeneration
$41.78 /

-0.17 (-0.41%)

GDNSF Goodness Growth
$1.59 /

-0.005 (-0.31%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$7.65 /

+ (+0.00%)

CLVR Clever Leaves
$9.94 /

-0.05 (-0.50%)

CGC Canopy Growth
$20.04 /

+0.45 (+2.30%)

CANN General Cannabis
/

+

ACB Aurora Cannabis
$7.31 /

+0.025 (+0.34%)

ZYNE Zynerba
$4.62 /

-0.06 (-1.28%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
IGC India Globalization Capital
$1.87 /

-0.01 (-0.53%)

02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
GTBIF Green Thumb Industries
$29.60 /

+0.36 (+1.23%)

07/07/21 Jefferies
Green Thumb Industries initiated with a Buy at Jefferies
05/13/21 Canaccord
Green Thumb Industries price target raised to C$54 from C$52 at Canaccord
03/29/21 Alliance Global Partners
NY cannabis bill 'big win' for Acreage and Curaleaf, says Alliance Global
03/18/21 Craig-Hallum
Green Thumb Industries price target raised to $60 from $55 at Craig-Hallum
GDNSF Goodness Growth
$1.59 /

-0.005 (-0.31%)

CANN General Cannabis
/

+

CVSI CV Sciences
/

+

03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
CRON Cronos Group
$7.65 /

+ (+0.00%)

04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/28/21 BofA
BofA reinstates Cronos Group at Underperform with $7.50 price target
04/28/21 BofA
Cronos Group reinitiated with an Underperform at BofA
CGC Canopy Growth
$20.04 /

+0.45 (+2.30%)

07/08/21 Piper Sandler
Canopy Growth price target lowered to $24 from $27 at Piper Sandler
06/03/21 Desjardins
Canopy Growth price target lowered to C$35 from C$55 at Desjardins
06/02/21 CIBC
Canopy Growth price target lowered to C$36 from C$38 at CIBC
CTST CannTrust
/

+

ACB Aurora Cannabis
$7.31 /

+0.025 (+0.34%)

05/17/21 CIBC
Aurora Cannabis price target lowered to C$8 from C$9 at CIBC
05/14/21
Fly Intel: Top five analyst downgrades
05/14/21 Canaccord
Aurora Cannabis downgraded to Sell from Hold at Canaccord
TCNNF Trulieve Cannabis
$32.36 /

+0.94 (+2.99%)

07/07/21 Jefferies
Trulieve Cannabis initiated with a Buy at Jefferies
05/12/21 Canaccord
Trulieve Cannabis price target raised to C$97 from C$90 at Canaccord
05/12/21 Stifel
Trulieve Cannabis price target raised to C$132 from C$118 at Stifel
CLVR Clever Leaves
$9.94 /

-0.05 (-0.50%)

07/27/21 Canaccord
Canaccord starts 'uniquely positioned' Clever Leaves with Buy
07/27/21 Canaccord
Clever Leaves initiated with a Buy at Canaccord
07/23/21 Cowen
Cowen starts 'show-me' story Clever Leaves at Market Perform
07/23/21 Cowen
Clever Leaves initiated with a Market Perform at Cowen
IMCC IM Cannabis
$5.13 /

+0.06 (+1.18%)

07/29/21 Alliance Global Partners
Israel cannabis bill fails but market still robust, says Alliance Global Partner
07/15/21 Desjardins
Desjardins starts IM Cannabis with Buy on multi-country exposure
07/13/21 Desjardins
IM Cannabis initiated with a Buy at Desjardins
06/10/21 Alliance Global Partners
IM Cannabis initiated with a Buy at Alliance Global Partners
GRWG GrowGeneration
$41.78 /

-0.17 (-0.41%)

07/20/21 Lake Street
GrowGeneration executing on growth strategy with new purchase, says Lake Street
06/03/21 Oppenheimer
OpCo bullish on GrowGeneration as Amazon throws weight behind legalization
05/14/21 Alliance Global Partners
GrowGeneration upgraded to Buy from Neutral at Alliance Global Partners
05/14/21 Ladenburg
Ladenburg upgrades GrowGeneration to Buy, says 'growing at all fronts'
TLRY Tilray
$16.14 /

+0.14 (+0.88%)

07/28/21 Roth Capital
Tilray positioned for further consolidation, says Roth Capital
06/30/21 MKM Partners
Tilray price target raised to $16 from $8.50 at MKM Partners
06/23/21 Alliance Global Partners
Tilray price target lowered to $18 from $32 at Alliance Global Partners
ZYNE Zynerba
$4.62 /

-0.06 (-1.28%)

TLRY Tilray
$16.14 /

+0.14 (+0.88%)

IMCC IM Cannabis
$5.13 /

+0.06 (+1.18%)

GRWG GrowGeneration
$41.78 /

-0.17 (-0.41%)

CRON Cronos Group
$7.65 /

+ (+0.00%)

CGC Canopy Growth
$20.04 /

+0.45 (+2.30%)

ACB Aurora Cannabis
$7.31 /

+0.025 (+0.34%)

  • 22
    Jan
  • 09
    Dec
  • 11
    Nov
ZYNE Zynerba
$4.62 /

-0.06 (-1.28%)

GTBIF Green Thumb Industries
$29.60 /

+0.36 (+1.23%)

ZYNE Zynerba
$4.62 /

-0.06 (-1.28%)

TLRY Tilray
$16.14 /

+0.14 (+0.88%)

IMCC IM Cannabis
$5.13 /

+0.06 (+1.18%)

IGC India Globalization Capital
$1.87 /

-0.01 (-0.53%)

GRWG GrowGeneration
$41.78 /

-0.17 (-0.41%)

GDNSF Goodness Growth
$1.59 /

-0.005 (-0.31%)

CRON Cronos Group
$7.65 /

+ (+0.00%)

CLVR Clever Leaves
$9.94 /

-0.05 (-0.50%)

ZYNE Zynerba
$4.62 /

-0.06 (-1.28%)

TLRY Tilray
$16.14 /

+0.14 (+0.88%)

IGC India Globalization Capital
$1.87 /

-0.01 (-0.53%)

GRWG GrowGeneration
$41.78 /

-0.17 (-0.41%)

CRON Cronos Group
$7.65 /

+ (+0.00%)

CLVR Clever Leaves
$9.94 /

-0.05 (-0.50%)

CGC Canopy Growth
$20.04 /

+0.45 (+2.30%)

ACB Aurora Cannabis
$7.31 /

+0.025 (+0.34%)

Tuesday
Hot Stocks
Clever Leaves, Biopharmaceutical Research partner for cannabis research study » 08:21
07/27/21
07/27
08:21
07/27/21
08:21
CLVR

Clever Leaves

$9.60 /

+0.56 (+6.19%)

Clever Leaves Holdings…

Clever Leaves Holdings announced a joint partnership with the intent to study the DNA sequence variation of three Clever Leaves' cannabis cultivars as part of their Project Change Lives campaign. The University of California, Davis, through an accepted research sponsorship from BRC, will lead the extraction and analysis of DNA to elucidate genetic variants taken from various genetic lines of Cannabis sativa. Project Change Lives is a US-based initiative sponsored by Clever Leaves, whereby the Company has pledged to contribute up to $25,000,000 retail value of medical cannabis products to any eligible U.S. organization to help advance scientific research into the potential medical benefits of cannabinoids. By sponsoring Project Change Lives, Clever Leaves is offering to provide a historic amount of pharmaceutical-grade cannabis to leading research institutions in one of the most advanced pharmaceutical markets in the world. UC Davis will be the first major research institution to collaborate in the investigation of Clever Leaves' Colombian and Portuguese, pharmaceutical-grade cannabis as part of Project Change Lives. Clever Leaves will provide three of its cultivars to BRC for analysis at their facilities. Researchers from UC Davis will extract DNA for sequencing and analysis from the cannabis samples at the BRC facilities. The UC Davis scientists will also test new approaches to extract RNA from dried material. If successful, researchers will analyze the data to quantify global gene expression and will use available pipelines to determine differential gene expression between the three lines sampled. These data will provide foundational information to initiate new crosses and a breeding pipeline for the future to ensure the genetic variation of Cannabis sativa can be utilized to provide novel and unique medicinal cannabis for new pharmaceuticals. Moreover, analysis of the completed data will reveal the correlation between specific genotypes of cannabis and the biochemical phenotypes for cannabinoids and terpenes. Upon completion of the study, UC Davis intends to provide a report that provides insight into the genetic diversity of the lines and the feasibility of RNA extraction and gene expression from dried Cannabis sativa material. These findings will be made widely available for the benefit of the medical and scientific community - a result that meets one of the key goals of Project Change Lives.

ShowHide Related Items >><<
CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

07/27/21 Canaccord
Canaccord starts 'uniquely positioned' Clever Leaves with Buy
07/27/21 Canaccord
Clever Leaves initiated with a Buy at Canaccord
07/23/21 Cowen
Cowen starts 'show-me' story Clever Leaves at Market Perform
07/23/21 Cowen
Clever Leaves initiated with a Market Perform at Cowen
CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

Initiation
Canaccord starts 'uniquely positioned' Clever Leaves with Buy » 07:20
07/27/21
07/27
07:20
07/27/21
07:20
CLVR

Clever Leaves

$9.60 /

+0.56 (+6.19%)

Canaccord Genuity analyst…

Canaccord Genuity analyst Bobby Burleson initiated coverage of Clever Leaves with a Buy rating and $13 price target. The analyst believes the company is "uniquely positioned" as a low-cost producer of flower and extracts through its Colombian cultivation and extraction facility, particularly following Colombia's recent decree lifting restrictions on flower exports. Clover's Nasdaq listing "further differentiates the company" by attracting institutional investor capital and allowing access to debt at more conventional costs, Burleson tells investors in a research note. He believes the stock is deserving of a premium valuation.

ShowHide Related Items >><<
CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

07/27/21 Canaccord
Clever Leaves initiated with a Buy at Canaccord
07/23/21 Cowen
Cowen starts 'show-me' story Clever Leaves at Market Perform
07/23/21 Cowen
Clever Leaves initiated with a Market Perform at Cowen
CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

Initiation
Clever Leaves initiated with a Buy at Canaccord » 06:19
07/27/21
07/27
06:19
07/27/21
06:19
CLVR

Clever Leaves

$9.60 /

+0.56 (+6.19%)

Canaccord analyst Bobby…

Canaccord analyst Bobby Burleson initiated coverage of Clever Leaves with a Buy rating and $13 price target.

ShowHide Related Items >><<
CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

07/23/21 Cowen
Cowen starts 'show-me' story Clever Leaves at Market Perform
07/23/21 Cowen
Clever Leaves initiated with a Market Perform at Cowen
CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

CLVR Clever Leaves
$9.60 /

+0.56 (+6.19%)

Over a week ago
Hot Stocks
Clever Leaves to 'take advantage' of cannabis flower export approval in Colombia » 17:49
07/23/21
07/23
17:49
07/23/21
17:49
CLVR

Clever Leaves

$9.04 /

-0.21 (-2.27%)

Clever Leaves Holdings…

Clever Leaves Holdings hosted Colombian President Duque at its cultivation facility in Colombia for the signing of a new decree that allows Colombian licensed cannabis companies such as Clever Leaves to participate in the commercial production and export of medical cannabis flower. With flower representing an estimated 50% of the global medical cannabis markets, this decree doubles the total addressable market for Colombian cannabis producers. "Clever Leaves is well-positioned to take advantage of this opportunity to export dried cannabis flower, leveraging its 1.8 million sq. ft. CUMCS GACP certified cultivation facility, its EUGMP Part II certification covering the production of dry flower, and its 30-plus cannabinoid genetics registered in the country," the company said. "Colombia's environmental conditions, coupled with Clever Leaves' experience in sustainable cannabis growing, will allow the company to bring to market unique products with pharmaceutical quality. Colombian flower complements Clever Leaves' already strong Portuguese flower production, allowing the company to present a comprehensive portfolio, covering different strains and growing conditions, that will suit ever-evolving patient needs. Having shipped cannabis products to over 15 countries in five continents, Clever Leaves has a strong network of partners globally, who will benefit from its broader flower offering. Clever Leaves will leverage its position as a trusted B2B partner to develop and produce high quality and innovative products for medical cannabis patients around the world. This change in regulation, allowing for the export of dried flower, will catalyze the continued development of the Colombian medical cannabis industry by eliminating the restriction that blocked access to 50% of the global medical cannabis market. In addition, the decree includes features that will help Clever Leaves to drive additional growth, including streamlined processes in quota management systems, which enable efficiencies and improve Clever Leaves' ability to serve clients faster. The bill also includes access to medical cannabis for patients in Colombia."

ShowHide Related Items >><<
CLVR Clever Leaves
$9.04 /

-0.21 (-2.27%)

CLVR Clever Leaves
$9.04 /

-0.21 (-2.27%)

07/23/21 Cowen
Cowen starts 'show-me' story Clever Leaves at Market Perform
07/23/21 Cowen
Clever Leaves initiated with a Market Perform at Cowen
CLVR Clever Leaves
$9.04 /

-0.21 (-2.27%)

CLVR Clever Leaves
$9.04 /

-0.21 (-2.27%)

Initiation
Cowen starts 'show-me' story Clever Leaves at Market Perform » 08:23
07/23/21
07/23
08:23
07/23/21
08:23
CLVR

Clever Leaves

$9.04 /

-0.13 (-1.42%)

Cowen analyst Vivien Azer…

Cowen analyst Vivien Azer initiated coverage of Clever Leaves with a Market Perform rating and $10 price target. Clever is a first mover in the low-cost global, multi-national cannabis market, with cultivation infrastructure in Colombia and Portugal, Azer tells investors in a research note. The analyst says that while the company's total addressable market and medium-term margin profile are attractive, its revenue generation will take time as it scales global export relationships. Azer views Clever Leaves as a "show-me" story.

ShowHide Related Items >><<
CLVR Clever Leaves
$9.04 /

-0.13 (-1.42%)

CLVR Clever Leaves
$9.04 /

-0.13 (-1.42%)

07/23/21 Cowen
Clever Leaves initiated with a Market Perform at Cowen
CLVR Clever Leaves
$9.04 /

-0.13 (-1.42%)

CLVR Clever Leaves
$9.04 /

-0.13 (-1.42%)

Initiation
Clever Leaves initiated with a Market Perform at Cowen » 06:05
07/23/21
07/23
06:05
07/23/21
06:05
CLVR

Clever Leaves

/

+

Cowen analyst Vivien Azer…

Cowen analyst Vivien Azer initiated coverage of Clever Leaves with a Market Perform rating.

ShowHide Related Items >><<
CLVR Clever Leaves
/

+

CLVR Clever Leaves
/

+

CLVR Clever Leaves
/

+

Over a month ago
Hot Stocks
Clever Leaves launches research initiative Project Change Lives » 08:49
06/28/21
06/28
08:49
06/28/21
08:49
CLVR

Clever Leaves

$10.89 /

+0.49 (+4.71%)

Clever Leaves Holdings…

Clever Leaves Holdings announces Project Change Lives, a U.S. focused research initiative, whereby the Company has pledged to contribute up to $25,000,000 retail value of medical cannabis products to any eligible U.S. organization to help advance scientific research into the potential medical benefits of cannabinoids. By sponsoring Project Change Lives, Clever Leaves is offering to provide a historic amount of pharmaceutical-grade cannabis to leading research institutions in one of the most advanced pharmaceutical markets in the world. Clever Leaves is looking to supply up to 250,000 bottles of pharmaceutical-grade cannabis oils or approximately 5 tons of medical cannabis flower that will help research institutions develop new therapies. To eliminate an additional impediment to the advancement of scientific knowledge around cannabis, this research material will be provided at no cost to Clever Leaves' research partners. The Company will be partnering with Biopharmaceutical Research Company, a company which holds federal licenses for importing, analyzing and manufacturing controlled substances, as its importer of record. Clever Leaves plans to begin working with U.S. investigators immediately and initiate their efforts with a research study focused on the DNA sequencing of a variety of their cannabis cultivars.

ShowHide Related Items >><<
CLVR Clever Leaves
$10.89 /

+0.49 (+4.71%)

CLVR Clever Leaves
$10.89 /

+0.49 (+4.71%)

CLVR Clever Leaves
$10.89 /

+0.49 (+4.71%)

Conference/Events
Clever Leaves participates in a conference call with MKM Partners » 04:55
06/24/21
06/24
04:55
06/24/21
04:55
CLVR

Clever Leaves

$10.40 /

+0.29 (+2.87%)

Conference call with CEO…

Conference call with CEO Detwiler and CFO Hague will be held on June 24 hosted by MKM Partners.

ShowHide Related Items >><<
CLVR Clever Leaves
$10.40 /

+0.29 (+2.87%)

CLVR Clever Leaves
$10.40 /

+0.29 (+2.87%)

CLVR Clever Leaves
$10.40 /

+0.29 (+2.87%)

On The Fly
Rising High: Analyst more cautious on Tilray despite legalization bill » 12:08
06/17/21
06/17
12:08
06/17/21
12:08
CGC

Canopy Growth

$23.98 /

-0.13 (-0.54%)

, SPRWF

Supreme Cannabis

/

+

, TCNNF

Trulieve Cannabis

$35.70 /

+0.1 (+0.28%)

, IGC

India Globalization Capital

$1.57 /

-0.015 (-0.95%)

, CANN

General Cannabis

/

+

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, ACB

Aurora Cannabis

$9.19 /

-0.07 (-0.76%)

, KERN

Akerna

$4.44 /

+0.12 (+2.78%)

, ZYNE

Zynerba

$5.57 /

-0.04 (-0.71%)

, CRON

Cronos Group

$8.62 /

+0.005 (+0.06%)

, CLVR

Clever Leaves

$10.74 /

-0.11 (-1.01%)

, HEXO

Hexo

$5.79 /

-0.095 (-1.61%)

, TLRY

Tilray

$17.94 /

-0.19 (-1.05%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
$5.57 /

-0.04 (-0.71%)

TLRY Tilray
$17.94 /

-0.19 (-1.05%)

TCNNF Trulieve Cannabis
$35.70 /

+0.1 (+0.28%)

SPRWF Supreme Cannabis
/

+

KERN Akerna
$4.44 /

+0.12 (+2.78%)

IGC India Globalization Capital
$1.57 /

-0.015 (-0.95%)

HEXO Hexo
$5.79 /

-0.095 (-1.61%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$8.62 /

+0.005 (+0.06%)

CLVR Clever Leaves
$10.74 /

-0.11 (-1.01%)

CGC Canopy Growth
$23.98 /

-0.13 (-0.54%)

CANN General Cannabis
/

+

ACB Aurora Cannabis
$9.19 /

-0.07 (-0.76%)

CGC Canopy Growth
$23.98 /

-0.13 (-0.54%)

06/03/21 Desjardins
Canopy Growth price target lowered to C$35 from C$55 at Desjardins
06/02/21 CIBC
Canopy Growth price target lowered to C$36 from C$38 at CIBC
06/02/21
Fly Intel: Top five analyst upgrades
06/02/21 MKM Partners
Canopy Growth price target lowered to C$51 from C$55 at MKM Partners
SPRWF Supreme Cannabis
/

+

04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
03/10/21 BMO Capital
Supreme Cannabis upgraded to Outperform from Market Perform at BMO Capital
02/16/21 Stifel
Supreme Cannabis price target raised to C$0.55 from C$0.20 at Stifel
TCNNF Trulieve Cannabis
$35.70 /

+0.1 (+0.28%)

05/12/21 Canaccord
Trulieve Cannabis price target raised to C$97 from C$90 at Canaccord
05/12/21 Stifel
Trulieve Cannabis price target raised to C$132 from C$118 at Stifel
05/10/21 Roth Capital
Trulieve deal for Harvest Health 'strategic vs. synergistic,' says Roth Capital
04/15/21 Cowen
Trulieve Cannabis initiated with an Outperform at Cowen
IGC India Globalization Capital
$1.57 /

-0.015 (-0.95%)

03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
CANN General Cannabis
/

+

CVSI CV Sciences
/

+

03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
CTST CannTrust
/

+

ACB Aurora Cannabis
$9.19 /

-0.07 (-0.76%)

05/17/21 CIBC
Aurora Cannabis price target lowered to C$8 from C$9 at CIBC
05/14/21
Fly Intel: Top five analyst downgrades
05/14/21 Canaccord
Aurora Cannabis downgraded to Sell from Hold at Canaccord
05/14/21 BMO Capital
Aurora Cannabis upgraded to Market Perform from Underperform at BMO Capital
KERN Akerna
$4.44 /

+0.12 (+2.78%)

02/05/21 Alliance Global Partners
Akerna price target raised to $10.50 from $8 at Alliance Global Partners
11/12/20 Alliance Global Partners
Akerna price target lowered to $8 from $10 at Alliance Global Partners
11/04/20 Alliance Global Partners
Five states legalize cannabis, bullish for Akerna, says Alliance Global Partners
09/24/20 Alliance Global Partners
Akerna post-earnings selloff overdone, says Alliance Global Partners
ZYNE Zynerba
$5.57 /

-0.04 (-0.71%)

05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
02/03/21 Ladenburg
Jazz deal for GW 'spotlights' value of Zynerba CBD products, says Ladenburg
CRON Cronos Group
$8.62 /

+0.005 (+0.06%)

04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/28/21 BofA
BofA reinstates Cronos Group at Underperform with $7.50 price target
04/28/21 BofA
Cronos Group reinitiated with an Underperform at BofA
CLVR Clever Leaves
$10.74 /

-0.11 (-1.01%)

HEXO Hexo
$5.79 /

-0.095 (-1.61%)

06/16/21 Desjardins
Hexo price target lowered to C$7.50 from C$8 at Desjardins
06/15/21 Canaccord
Hexo price target lowered to C$7 from C$9 at Canaccord
06/15/21 CIBC
Hexo price target lowered to C$10 from C$13.50 at CIBC
05/28/21 Stifel
Hexo has risk of facing competing bidder for Redecan, says Stifel
TLRY Tilray
$17.94 /

-0.19 (-1.05%)

06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 CIBC
Tilray downgraded to Neutral after 33% rally at CIBC
06/10/21 CIBC
Tilray downgraded to Neutral from Outperformer at CIBC
06/03/21
Fly Intel: Top five analyst upgrades
ZYNE Zynerba
$5.57 /

-0.04 (-0.71%)

TLRY Tilray
$17.94 /

-0.19 (-1.05%)

CRON Cronos Group
$8.62 /

+0.005 (+0.06%)

CGC Canopy Growth
$23.98 /

-0.13 (-0.54%)

ACB Aurora Cannabis
$9.19 /

-0.07 (-0.76%)

  • 22
    Jan
  • 11
    Nov
SPRWF Supreme Cannabis
/

+

IGC India Globalization Capital
$1.57 /

-0.015 (-0.95%)

CTST CannTrust
/

+

CGC Canopy Growth
$23.98 /

-0.13 (-0.54%)

TLRY Tilray
$17.94 /

-0.19 (-1.05%)

TCNNF Trulieve Cannabis
$35.70 /

+0.1 (+0.28%)

SPRWF Supreme Cannabis
/

+

HEXO Hexo
$5.79 /

-0.095 (-1.61%)

CLVR Clever Leaves
$10.74 /

-0.11 (-1.01%)

CGC Canopy Growth
$23.98 /

-0.13 (-0.54%)

ZYNE Zynerba
$5.57 /

-0.04 (-0.71%)

TLRY Tilray
$17.94 /

-0.19 (-1.05%)

KERN Akerna
$4.44 /

+0.12 (+2.78%)

IGC India Globalization Capital
$1.57 /

-0.015 (-0.95%)

HEXO Hexo
$5.79 /

-0.095 (-1.61%)

CRON Cronos Group
$8.62 /

+0.005 (+0.06%)

CLVR Clever Leaves
$10.74 /

-0.11 (-1.01%)

CGC Canopy Growth
$23.98 /

-0.13 (-0.54%)

ACB Aurora Cannabis
$9.19 /

-0.07 (-0.76%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.